FMR LLC 13D and 13G filings for Crinetics Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-05-12 10:28 am Purchase | 2025-03-31 | 13G | Crinetics Pharmaceuticals, Inc. CRNX | FMR LLC | 13,957,269 15.000% | 4,325,631 (+44.91%) | Filing |
| 2025-02-07 10:23 am Purchase | 2025-01-31 | 13G | Crinetics Pharmaceuticals, Inc. CRNX | FMR LLC | 9,631,638 10.400% | 727,552 (+8.17%) | Filing |
| 2025-02-07 10:06 am Purchase | 2024-12-31 | 13G | Crinetics Pharmaceuticals, Inc. CRNX | FMR LLC | 8,904,086 9.600% | 8,904,086 (New Position) | Filing |